DEXILANT 30 MG CAP DURA LIB RETARD CT BL AL AL X 10

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1063902610027
  • GGREM 501112070019202
  • Código de barras 7896641808975

O que a fonte publica

Detentor do registro
TAKEDA PHARMA LTDA.
Princípios ativos
DEXLANSOPRAZOL
Embalagem
30 MG CAP DURA LIB RETARD CT BL AL AL X 10
Regime de dispensação
Tarja Vermelha
Tipo de produto
Novo
Classe terapêutica
A2B2 - INIBIDORES DA BOMBA DE PRÓTONS
Prescrição
Sob prescrição ou restrito

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:501112070019202
{
  "name": "DEXILANT 30 MG CAP DURA LIB RETARD CT BL AL AL X 10",
  "holder": "TAKEDA PHARMA LTDA.",
  "stripe": "Tarja Vermelha",
  "barcodes": [
    "7896641808975"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "501112070019202",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "60.397.775/0001-74",
  "priceRegime": "Regulado",
  "productName": "DEXILANT",
  "productType": "Novo",
  "hospitalOnly": false,
  "presentation": "30 MG CAP DURA LIB RETARD CT BL AL AL X 10",
  "sourceStatus": null,
  "supplyRegime": "Tarja Vermelha",
  "factoryPrices": {
    "icms-0": "22.72",
    "icms-12": "25.82",
    "icms-17": "27.37",
    "icms-18": "27.71",
    "icms-19": "28.05",
    "icms-20": "28.40",
    "icms-21": "28.76",
    "icms-22": "29.13",
    "icms-23": "29.51",
    "icms-17.5": "27.54",
    "icms-19.5": "28.22",
    "icms-20.5": "28.58",
    "icms-22.5": "29.32",
    "icms-12-alc": "23.05",
    "icms-17-alc": "24.44",
    "icms-18-alc": "24.74",
    "icms-19-alc": "25.04",
    "icms-20-alc": "25.36",
    "icms-21-alc": "25.68",
    "icms-22-alc": "26.01",
    "icms-23-alc": "26.35",
    "withoutTaxes": "20.29",
    "icms-17.5-alc": "24.59",
    "icms-19.5-alc": "25.20",
    "icms-20.5-alc": "25.52",
    "icms-22.5-alc": "26.18"
  },
  "pisCofinsList": "Negativa",
  "substanceText": "DEXLANSOPRAZOL",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "30.48",
    "icms-12": "34.64",
    "icms-17": "36.72",
    "icms-18": "37.17",
    "icms-19": "37.63",
    "icms-20": "38.10",
    "icms-21": "38.58",
    "icms-22": "39.08",
    "icms-23": "39.59",
    "icms-17.5": "36.94",
    "icms-19.5": "37.86",
    "icms-20.5": "38.34",
    "icms-22.5": "39.33",
    "icms-12-alc": "31.87",
    "icms-17-alc": "33.79",
    "icms-18-alc": "34.20",
    "icms-19-alc": "34.62",
    "icms-20-alc": "35.06",
    "icms-21-alc": "35.50",
    "icms-22-alc": "35.96",
    "icms-23-alc": "36.43",
    "withoutTaxes": "28.04",
    "icms-17.5-alc": "33.99",
    "icms-19.5-alc": "34.84",
    "icms-20.5-alc": "35.28",
    "icms-22.5-alc": "36.19"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "DEXLANSOPRAZOL"
  ],
  "therapeuticClass": "A2B2 - INIBIDORES DA BOMBA DE PRÓTONS",
  "commercialisation": {
    "year": 2025,
    "marketed": false
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1063902610027",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "prescription-or-restricted",
  "prescriptionRequired": true,
  "therapeuticClassCode": "A2B2",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:501112070019202"